Medtronic plc (LON:0Y6X)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 94.54B |
| Revenue (ttm) | 26.12B |
| Net Income (ttm) | 3.58B |
| Shares Out | n/a |
| EPS (ttm) | 2.77 |
| PE Ratio | 26.40 |
| Forward PE | 16.80 |
| Dividend | 2.14 (2.17%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | 1,423 |
| Average Volume | 6,923 |
| Open | 98.73 |
| Previous Close | 98.61 |
| Day's Range | 97.91 - 99.52 |
| 52-Week Range | 79.31 - 106.66 |
| Beta | 0.72 |
| RSI | 49.61 |
| Earnings Date | Feb 17, 2026 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Medtronic: A Defensive Gem For Uncertain Times
Medtronic (MDT) is a strong defensive investment with stable growth, 49 years of dividend increases, and fair value. Read here for more analysis.
Medtronic's Diabetes Unit MiniMed Files For US IPO
Medtronic ‘s (NYSE: MDT) diabetes unit, MiniMed Group, filed for a U.S. initial public offering (IPO) on Friday, as part of its separation from the medical devices maker. The Northridge, California-b...
Medtronic's Diabetes Unit MiniMed Files For IPO On Nasdaq
(RTTNews) - Medtronic plc (MDT) announced that its Diabetes division—set to operate under the name MiniMed—has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commissi...
Medtronic (MDT) Plans IPO for MiniMed Diabetes Business
Medtronic (MDT) Plans IPO for MiniMed Diabetes Business
Medtronic Spin-Off MiniMed Files for IPO
Medtronic will own at least 80.1% of the voting stock for MiniMed once the IPO is complete.
Medtronic (MDT) Plans MiniMed IPO to Boost Diabetes Business
Medtronic (MDT) Plans MiniMed IPO to Boost Diabetes Business
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
GALWAY, Ireland , Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will oper...
Medtronic's MiniMed files for US IPO
MiniMed Group, the diabetes business of medical device maker Medtronic , filed for an initial public offering in the United States on Friday.
Medtronic (MDT): Truist Securities Lowers Price Target, Reaffirms Hold Rating | MDT Stock News
Medtronic (MDT): Truist Securities Lowers Price Target, Reaffirms Hold Rating | MDT Stock News
Why Is Medtronic (MDT) Down 2% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dividend Income: Lanny's October 2025 Summary
In October, we (my wife and I) received a dividend income total of $3,948.78. Crushing it for an off-month – thanks to Vanguard (VOO) and Fidelity (FXAIX) for paying in October. We had quite a few div...
This Dividend Stock Just Hit a Major Milestone. Time to Buy?
Medtronic earned regulatory clearance in the U.S. for its Hugo robotic-assisted surgery system. This device will take time to have a material impact on the company's financial results.
3 Dividend Stocks to Hold for the Next 10 Years
If you are looking for dividend stocks that you can buy and hold, consider UPS, General Mills, and Medtronic.
Hot Picks: Large-cap health care stocks to watch for dividend growth
Portfolio manager highlights AbbVie, Pfizer and Medtronic as compelling large-cap health care dividend plays with growth and valuation support.
Medtronic: This Dividend Aristocrat Is Just Getting Started
3 No-Brainer Dividend Stocks to Buy Right Now
Enterprise Products Partners will produce significantly more free cash flow in 2026. Medtronic is only two years away from achieving a rare dividend milestone.
Forget Medtronic, Buy This Healthcare Stock Instead
That is, if you can handle more volatility.
Medtronic (MDT) Upgraded to Buy: Here's Why
Medtronic (MDT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Medtronic (MDT) Maintains Quarterly Dividend of $0.71 Per Share
Medtronic (MDT) Maintains Quarterly Dividend of $0.71 Per Share
Medtronic announces cash dividend for third quarter of fiscal year 2026
GALWAY, Ireland , Dec. 4, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal y...
Medtronic Scores FDA Win As Hugo Surgical Robot Enters 230,000 Urology Procedure Market
On Wednesday, the U.S. Food and Drug Administration (FDA) cleared Medtronic Plc’s (NYSE: MDT) Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures . MDT is in positive t...
Prediction: 1 Healthcare Giant Set to Soar in 2026
Medtronic recently delivered strong quarterly results thanks to a fast-growing franchise. This tailwind, along with others, could help maintain the stock's momentum into 2026.
FDA Clears Medtronic's Hugo Robotic-Assisted Surgery System For Urologic Procedures
(RTTNews) - Medtronic (MDT) announced that it has received FDA clearance for its Hugo robotic-assisted surgery (RAS) system in urologic procedures, marking a significant milestone in its surgical inno...
Medtronic (MDT) Gains FDA Approval for Hugo Robotic Surgery System
Medtronic (MDT) Gains FDA Approval for Hugo Robotic Surgery System
Medtronic (MDT) Secures FDA Approval for Hugo Robotic Surgery System
Medtronic (MDT) Secures FDA Approval for Hugo Robotic Surgery System